Dr. Nitin Rohatgi graduated from the All India Institute of Medical Sciences, Delhi and later on did his residency in Internal Medicine at the University of Massachusetts Memorial Healthcare. He also did a fellowship in Hematology/Oncology at the University Hospital –University of Cincinnati College of Medicine. Dr. Rohatgi has been certified by the American Board of Internal Medicine in the field of Medical Oncology. He is practicing for more than 20 years and is currently associated with the Sutter Medical Center-Sacramento. He has also contributed to two research publications.
Dr. Nitin Rohatgi has contributed to 2 publications.
Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.
Rohatgi, N., LaRocca, R. V., Bard, V., Sethuraman, G., Foon, K. A.; Am J Hematol. 2002 Jul.
Dr. Nitin Rohatgi graduated from the All India Institute of Medical Sciences, Delhi and later on did his residency in Internal Medicine at the University of Massachusetts Memorial Healthcare. He also did a fellowship in Hematology/Oncology at the University Hospital –University of Cincinnati College of Medicine. Dr. Rohatgi has been certified by the American Board of Internal Medicine in the field of Medical Oncology. He is practicing for more than 20 years and is currently associated with the Sutter Medical Center-Sacramento. He has also contributed to two research publications.
Dr. Nitin Rohatgi has contributed to 2 publications.
Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.
Rohatgi, N., LaRocca, R. V., Bard, V., Sethuraman, G., Foon, K. A.; Am J Hematol. 2002 Jul.